Watson Pharmaceuticals (WPI +0.6%) says the European Commission has cleared its proposed...

Watson Pharmaceuticals (WPI+0.6%) says the European Commission has cleared its proposed acquisition of Swiss-based pharmaceutical company Actavis. The commission noted in its statement that "Despite significant changes in the competitive situation in some of the markets, a sufficient number of credible and strong competitors will continue to exercise a competitive constraint on the merged entity."